Publikasi Scopus 2024 per tanggal 29 Februari 2024 (130 artikel)

Thng Z.X.; Putera I.; Testi I.; Chan K.; Westcott M.; Chee S.-P.; Dick A.D.; Kempen J.H.; Bodaghi B.; Thorne J.E.; Barisani-Asenbauer T.; de Smet M.D.; Smith J.R.; McCluskey P.; La Distia Nora R.; Jabs D.A.; de Boer J.H.; Sen H.N.; Goldstein D.A.; Khairallah M.; Davis J.L.; Rosenbaum J.T.; Jones N.P.; Nguyen Q.D.; Pavesio C.; Agrawal R.; Gupta V.; Zierhut M.; Boer J.; Palestine A.; Denniston A.K.; Invernizzi A.; Radgonde A.; Kumar A.; Curi A.; Agarwal A.; Yee A.C.S.; Okada A.A.; Schlaen A.; Heiligenhaus A.; Gurbaxani A.; Murugan S.B.; Lee C.S.; Das D.; Baglivo E.; Carreño E.; Arevalo J.F.; Pichi F.; Uy H.; Al-Dhibi H.A.; Garweg J.G.; Biswas J.; Murthy K.B.; Caspers L.; Cimino L.; Lim L.L.; de la Maza M.S.; Agarwal M.; Mochizucki M.; Agarwal M.; Munk M.R.; Accorinti M.; Tyagi M.; Acharya N.; Mahendradas P.; Majumder P.D.; Murray P.I.; Lin P.; Neri P.; Bansal R.; Read R.W.; Mehta S.; Shawki S.S.S.; Mazumdar S.; Narain S.; Androudi S.; Murthy S.; Rathinam S.R.; Beng S.T.C.; Sridharan S.; Phatak S.; Tappeiner C.; Lai T.Y.Y.; Yuen Y.S.; Feng Y.
Thng, Zheng Xian (57203372016); Putera, Ikhwanuliman (56485949000); Testi, Ilaria (57190493331); Chan, Kevin (58795039000); Westcott, Mark (7003910861); Chee, Soon-Phaik (7005885793); Dick, Andrew D. (7103296976); Kempen, John H. (6603842682); Bodaghi, Bahram (56244598700); Thorne, Jennifer E. (57221279868); Barisani-Asenbauer, Talin (6601921047); de Smet, Marc D. (7006682778); Smith, Justine R. (58500776600); McCluskey, Peter (55598660500); La Distia Nora, Rina (56001881000); Jabs, Douglas A. (
57203372016; 56485949000; 57190493331; 58795039000; 7003910861; 7005885793; 7103296976; 6603842682; 56244598700; 57221279868; 6601921047; 7006682778; 58500776600; 55598660500; 56001881000; 58789320900; 7201921240; 7003412064; 7402147883; 7004503022; 7405960166; 57206434371; 56650499400; 55666336400; 7003495942; 7201475180; 35452834800; 57203252974; 58795274100; 7006252760; 54880010400; 36846060800; 58795274200; 58856292900; 6603554904; 57209565397; 56435555300; 7402333430; 6505774527; 7004464646; 16028184200; 57202223321; 56472056400; 35551118100; 6603901674; 36494045500; 58533545600; 53164582500; 6603825390; 8393725100; 7006639200; 7102648244; 57207751189; 8320551100; 7003872473; 15053336200; 58718744200; 20833248100; 58795039300; 57542422200; 54389904200; 6701349355; 54418168600; 15834058800; 58226086700; 56922253900; 35595791500; 7403225315; 16304917600; 7202185100; 7201365182; 9634993500; 58794576200; 57202781936; 16464738600; 6603286512; 7202013121; 57210661056; 58794565200; 12766892600; 24067663300; 25229140300; 7202203581; 57214457047; 57199165550
The Infectious Uveitis Treatment Algorithm Network (TITAN) Report 1—global current practice patterns for the management of Herpes Simplex Virus and Varicella Zoster Virus anterior uveitis
2024
Eye (Basingstoke)
38
1
61
67
6
0
National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore; Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia—Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia; Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, Netherlands; National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; Singapore National Eye Centre, Singapore, Singapore; Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; University of Bristol, Bristol, United Kingdom; UCL Institute of Ophthalmology, London, United Kingdom; Department of Ophthalmology, Massachusetts Eye and Ear/Harvard Medical School, and Schepens Eye Research Institute, Boston, MA, United States; Sight for Souls, Fort Myers, FL, United States; Department of Ophthalmology, Addis Ababa University, Addis Ababa, Ethiopia; MyungSung Christian Medical Center (MCM) Eye Unit, MCM General Hospital, and MyungSung Medical School, Addis Ababa, Ethiopia; Department of Ophthalmology, IHU FOReSIGHT, Sorbonne-APHP, 47-83 bd de l’Hopital, Paris, 75013, France; Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD, United States; Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria; Department of Ophthalmology, Leiden University, Leiden, Netherlands; MIOS sa, Lausanne, Switzerland; Flinders University College of Medicine and Public Health, Adelaide, SA, Australia; Queensland Eye Institute, Brisbane, QLD, Australia; Department of Ophthalmology, Save Sight Institute, The University of Sydney, Sydney, NSW, Australia; Department of Ophthalmology, Utrecht University Medical Center, Utrecht, Netherlands; National Eye Institute, National Institutes of Health, Bethesda, MD, United States; Feinberg School of Medicine, Northwestern University, Chicago, IL, United States; Department of Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia; Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United States; Oregon Health and Science University, Portland, OR, United States; Legacy Devers Eye Institute, Portland, OR, United States; School of Biological Sciences, University of Manchester, Manchester, United Kingdom; Byers Eye Institute, Stanford Medical School, Stanford, CA, United States; Duke NUS Medical School, Singapore, Singapore; Singapore Eye Research Institute, Singapore, Singapore; Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India
Thng Z.X., National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore; Putera I., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia—Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands, Department of Ophthalmology, Erasmus University Medical Center, Rotterdam, Netherlands; Testi I., National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom; Chan K., Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore; Westcott M., National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom; Chee S.-P., Singapore National Eye Centre, Singapore, Singapore, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore; Dick A.D., National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom, University of Bristol, Bristol, United Kingdom, UCL Institute of Ophthalmology, London, United Kingdom; Kempen J.H., Department of Ophthalmology, Massachusetts Eye and Ear/Harvard Medical School, and Schepens Eye Research Institute, Boston, MA, United States, Sight for Souls, Fort Myers, FL, United States, Department of Ophthalmology, Addis Ababa University, Addis Ababa, Ethiopia, MyungSung Christian Medical Center (MCM) Eye Unit, MCM General Hospital, and MyungSung Medical School, Addis Ababa, Ethiopia; Bodaghi B., Department of Ophthalmology, IHU FOReSIGHT, Sorbonne-APHP, 47-83 bd de l’Hopital, Paris, 75013, France; Thorne J.E., Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD, United States, Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; Barisani-Asenbauer T., Institute of Specific Prophylaxis and Tropical Medicine, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria; de Smet M.D., Department of Ophthalmology, Leiden University, Leiden, Netherlands, MIOS sa, Lausanne, Switzerland; Smith J.R., Flinders University College of Medicine and Public Health, Adelaide, SA, Australia, Queensland Eye Institute, Brisbane, QLD, Australia; McCluskey P., Department of Ophthalmology, Save Sight Institute, The University of Sydney, Sydney, NSW, Australia; La Distia Nora R., Department of Ophthalmology, Faculty of Medicine, Universitas Indonesia—Cipto Mangunkusumo Kirana Eye Hospital, Jakarta, Indonesia, Department of Immunology, Erasmus University Medical Center, Rotterdam, Netherlands; Jabs D.A., Wilmer Eye Institute, Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD, United States, Center for Clinical Trials and Evidence Synthesis, Department of Epidemiology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States; de Boer J.H., Department of Ophthalmology, Utrecht University Medical Center, Utrecht, Netherlands; Sen H.N., National Eye Institute, National Institutes of Health, Bethesda, MD, United States; Goldstein D.A., Feinberg School of Medicine, Northwestern University, Chicago, IL, United States; Khairallah M., Department of Ophthalmology, Fattouma Bourguiba University Hospital, Monastir, Tunisia; Davis J.L., Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United States; Rosenbaum J.T., Oregon Health and Science University, Portland, OR, United States, Legacy Devers Eye Institute, Portland, OR, United States; Jones N.P., School of Biological Sciences, University of Manchester, Manchester, United Kingdom; Nguyen Q.D., Byers Eye Institute, Stanford Medical School, Stanford, CA, United States; Pavesio C., National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom, University of Bristol, Bristol, United Kingdom; Agrawal R., National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore, National Institute for Health Research Biomedical Research Centre, Moorfields Eye Hospital, London, United Kingdom, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore, Duke NUS Medical School, Singapore, Singapore, Singapore Eye Research Institute, Singapore, Singapore; Gupta V., Advanced Eye Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India; Zierhut M.; Boer J.; Palestine A.; Denniston A.K.; Invernizzi A.; Radgonde A.; Kumar A.; Curi A.; Agarwal A.; Yee A.C.S.; Okada A.A.; Schlaen A.; Heiligenhaus A.; Gurbaxani A.; Murugan S.B.; Lee C.S.; Das D.; Baglivo E.; Carreño E.; Arevalo J.F.; Pichi F.; Uy H.; Al-Dhibi H.A.; Garweg J.G.; Biswas J.; Murthy K.B.; Caspers L.; Cimino L.; Lim L.L.; de la Maza M.S.; Agarwal M.; Mochizucki M.; Agarwal M.; Munk M.R.; Accorinti M.; Tyagi M.; Acharya N.; Mahendradas P.; Majumder P.D.; Murray P.I.; Lin P.; Neri P.; Bansal R.; Read R.W.; Mehta S.; Shawki S.S.S.; Mazumdar S.; Narain S.; Androudi S.; Murthy S.; Rathinam S.R.; Beng S.T.C.; Sridharan S.; Phatak S.; Tappeiner C.; Lai T.Y.Y.; Yuen Y.S.; Feng Y.
Aims: To present current expert practice patterns and to formulate a consensus for the management of HSV and VZV AU by uveitis specialists worldwide. Methods: A two-round online modified Delphi survey with masking of the study team was conducted. Responses were collected from 76 international uveitis experts from 21 countries. Current practices in the diagnosis and treatment of HSV and VZV AU were identified. A working group (The Infectious Uveitis Treatment Algorithm Network [TITAN]) developed data into consensus guidelines. Consensus is defined as a particular response towards a specific question meeting ≥75% of agreement or IQR ≤ 1 when a Likert scale is used. Results: Unilaterality, increased intraocular pressure (IOP), decreased corneal sensation and diffuse or sectoral iris atrophy are quite specific for HSV or VZV AU from consensus opinion. Sectoral iris atrophy is characteristic of HSV AU. Treatment initiation is highly variable, but most experts preferred valacyclovir owing to simpler dosing. Topical corticosteroids and beta-blockers should be used if necessary. Resolution of inflammation and normalisation of IOP are clinical endpoints. Conclusions: Consensus was reached on several aspects of diagnosis, choice of initial treatment, and treatment endpoints for HSV and VZV AU. Treatment duration and management of recurrences varied between experts. © 2023, The Author(s), under exclusive licence to The Royal College of Ophthalmologists.
Atrophy; Herpes Simplex; Herpes Zoster; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Simplexvirus; Uveitis; Uveitis, Anterior; aciclovir; beta adrenergic receptor blocking agent; corticosteroid; prednisolone acetate; valaciclovir; algorithm; antiviral therapy; Article; clinical feature; clinical outcome; clinical practice; consensus; corneal sensation; Delphi study; global current practice pattern; Herpes simplex virus; herpes zoster; human; inflammation; information processing; intraocular pressure; iridocyclitis; iris atrophy; Likert scale; masking of the study team; medical expert; medical parameters; medical specialist; ophthalmologist; practice guideline; response rate; sensation; study design; the infectious uveitis treatment algorithm network; treatment duration; treatm
Institute for Research on Poverty, IRP; Intramural Research Program, IRP; National Medical Research Council, NMRC
HNS’s work is supported by the NIH Intramural Research Program (IRP). The funding organisation had no role in the design or conduct of this research. RA has received NMRC Clinician Scientist Award from National Medical Research Council, Singapore, but the funding organisation has no role in the design or conduct of this research.
Springer Nature
0950222X
37419957
Article
#N/A
#N/A
#N/A